<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.dib.2021.107701"><dct:format>application/xml</dct:format><dct:title>Curation of an international drug proprietary names dataset</dct:title><dct:creator>Mohammad A. Khaleel</dct:creator><dct:creator>Amer Hayat Khan</dct:creator><dct:creator>S.M. Sheikh Ghadzi</dct:creator><dct:creator>Sami Alshakhshir</dct:creator><dct:subject><rdf:Bag><rdf:li>Drug list</rdf:li><rdf:li>Drug dataset</rdf:li><rdf:li>Drug database</rdf:li><rdf:li>Drug lexicon</rdf:li><rdf:li>Mapping to RxNorm</rdf:li><rdf:li>Proprietary drug name</rdf:li><rdf:li>Drug trade name</rdf:li><rdf:li>Drug active ingredient name</rdf:li></rdf:Bag></dct:subject><dct:description>Data in Brief 40 (2022). doi:10.1016/j.dib.2021.107701</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Data in Brief</prism:publicationName><prism:copyright>&#169; 2021 The Author(s). Published by Elsevier Inc.</prism:copyright><dct:publisher>Elsevier Inc.</dct:publisher><prism:issn>2352-3409</prism:issn><prism:volume>40</prism:volume><prism:coverDisplayDate>February 2022</prism:coverDisplayDate><prism:doi>10.1016/j.dib.2021.107701</prism:doi><prism:url>http://dx.doi.org/10.1016/j.dib.2021.107701</prism:url><dct:identifier>doi:10.1016/j.dib.2021.107701</dct:identifier><bam:articleNumber>107701</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-12-09T13:05:19Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S250.1</dp:version-number></dp:document-properties><ja:article docsubtype="dat" version="5.6" xml:lang="en"><ja:item-info><ja:jid>DIB</ja:jid><ja:aid>107701</ja:aid><ce:article-number>107701</ce:article-number><ce:pii>S2352-3409(21)00976-8</ce:pii><ce:doi>10.1016/j.dib.2021.107701</ce:doi><ce:copyright type="other" year="2021">The Author(s)</ce:copyright></ja:item-info><ja:head><ce:dochead id="dchd0001"><ce:textfn id="dhtxt0001">Data Article</ce:textfn></ce:dochead><ce:title id="tte0002">Curation of an international drug proprietary names dataset</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S2352340921009768-cff59c83ed9a57ccf0fe53ac3ae0c68f"><ce:given-name>Mohammad A.</ce:given-name><ce:surname>Khaleel</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/resources">Resources</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/data-curation">Data curation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/software">Software</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/validation">Validation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing &#x2013; original draft</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0001" type="email" xlink:href="mailto:m.khaleel@student.usm.my">m.khaleel@student.usm.my</ce:e-address><ce:e-address id="ead0001a" type="email" xlink:href="mailto:mamk77@yahoo.com">mamk77@yahoo.com</ce:e-address><ce:e-address id="ea3" type="social-media" xlink:href="https://twitter.com/mamk77">@mamk77</ce:e-address></ce:author><ce:author id="au0002" author-id="S2352340921009768-54edb7a69fe7acd7489844ce5a059774" orcid="0000-0003-4802-6181"><ce:given-name>Amer Hayat</ce:given-name><ce:surname>Khan</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0003" author-id="S2352340921009768-4e1bb88be2bd9b697bac4b704364066a" orcid="0000-0001-8855-8954"><ce:given-name>S.M. Sheikh</ce:given-name><ce:surname>Ghadzi</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0004" author-id="S2352340921009768-2a75e0bc040958fc8e288f9d3478df7d"><ce:given-name>Sami</ce:given-name><ce:surname>Alshakhshir</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/resources">Resources</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/validation">Validation</ce:contributor-role><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="aff0001" affiliation-id="S2352340921009768-8fdca646fdfaac45909c48b22ddcc310"><ce:label>a</ce:label><ce:textfn id="cetextfn0001">Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia</ce:textfn><sa:affiliation><sa:organization>Discipline of Clinical Pharmacy</sa:organization><sa:organization>School of Pharmaceutical Sciences</sa:organization><sa:organization>Universiti Sains Malaysia</sa:organization><sa:city>Penang</sa:city><sa:postal-code>11800</sa:postal-code><sa:country>Malaysia</sa:country></sa:affiliation><ce:source-text id="staff0001">aDiscipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia</ce:source-text></ce:affiliation><ce:affiliation id="aff0002" affiliation-id="S2352340921009768-d1b2b435ccf11569614890723534e50a"><ce:label>b</ce:label><ce:textfn id="cetextfn0002">Discipline of Clinical Pharmacy, School of Pharmacy, Aqaba University of Technology, Jordan</ce:textfn><sa:affiliation><sa:organization>Discipline of Clinical Pharmacy</sa:organization><sa:organization>School of Pharmacy</sa:organization><sa:organization>Aqaba University of Technology</sa:organization><sa:country>Jordan</sa:country></sa:affiliation><ce:source-text id="staff0002">bDiscipline of Clinical Pharmacy, School of Pharmacy, Aqaba University of Technology, Jordan</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text id="cetext0001">Corresponding author.</ce:text></ce:correspondence></ce:author-group><ce:date-received day="14" month="7" year="2021"/><ce:date-revised day="23" month="11" year="2021"/><ce:date-accepted day="8" month="12" year="2021"/><ce:abstract id="abs0001" view="all" class="author"><ce:section-title id="cesectitle0001">Abstract</ce:section-title><ce:abstract-sec id="abss0001" view="all"><ce:simple-para id="spara003" view="all">A drug dataset containing international proprietary names is essential for researchers investigating different drugs from different countries worldwide. However, many websites on the internet offer free access for a single drug searching service to identify international drug trade names, but not for a list of drugs to be searched and identified. Therefore, it will be problematic if the researcher has a list of hundreds or thousands of drug trade names to be identified. In this project, we have created an International Drug Dictionary (IDD) by curating collected drug lists from open access websites belonging to official drug regulatory agencies, official healthcare systems, or recognized scientific bodies from 44 countries around the world in addition to the European public assessment reports (EPAR) and the DRUGBANK vocabulary published in the public domain. Researchers interested in pharmacovigilance, pharmacoepidemiology, or pharmacoeconomics can benefit from this dataset, especially when identifying lists of proprietary drug names, particularly of multi-national origin.</ce:simple-para><ce:simple-para id="spara004" view="all">To enhance its adaptability, we also mapped the IDD to the standardized drug vocabulary RxNorm. The IDD can also be used as a tool for mapping international drug trade names to RxNorm. Each drug entity in the IDD mapped to a unique identification number for each entity called Atom Unique Identifier (RXAUI) from RxNorm.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0002">Keywords</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">Drug list</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">Drug dataset</ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Drug database</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">Drug lexicon</ce:text></ce:keyword><ce:keyword id="key0005"><ce:text id="cetext0006">Mapping to RxNorm</ce:text></ce:keyword><ce:keyword id="key0006"><ce:text id="cetext0007">Proprietary drug name</ce:text></ce:keyword><ce:keyword id="key0007"><ce:text id="cetext0008">Drug trade name</ce:text></ce:keyword><ce:keyword id="key0008"><ce:text id="cetext0009">Drug active ingredient name</ce:text></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
